Earnings Releases

Alignment Healthcare, Inc. reported first quarter ended March 31, 2024 results: revenue $628.6 million, net income $(46.6) million. Guidance raised.

“in such filing. --- EX-99.1 (PRESS RELEASE) --- EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Alignment Healthcare Reports First Quarter 2024 Results Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% y ear-over-year respectively Medicare Advantage membership grows 50.5% year-over-year to”

Longboard Pharmaceuticals, Inc. reported financial results for first quarter 2024.

“On May 2, 2024, Longboard Pharmaceuticals, Inc. ("Longboard") issued a press release announcing its financial results for the quarter ended March 31, 2024.”

Hippo Holdings Inc. reported the quarter ended March 31, 2024 results: revenue $85 million, net income $36 million.

“with Services and Insurance-as-a-Service (“IaaS”) representing 80% of TGP • Services and IaaS driving TGP growth, up 37% and 25% YoY, respectively in Q1 • Revenue up 114% YoY to $85 million; significantly better Revenue monetization in Hippo Home Insurance Program (“HHIP") Continued HHIP Loss Ratio Improvement • HHIP Q1 gross loss ratio improved 21pp YoY to 80% • Q1”

Dream Finders Homes, Inc. reported first quarter ended March 31, 2024 results: revenue $825 million, net income $54 million, EPS $0.55 per basic share.

“Securities Act of 1933, as amended, or the Exchange Act. --- EX-99.1 (EX-99.1) --- Dream Finders Announces First Quarter 2024 Results First Quarter Homebuilding Revenues of $825 million Net New Orders Up 19% , Net Income to DFH Up 11% Return on Participating Equity of 34.9% Jacksonville, FL. — May 2, 2024 — Dream Finders Homes, Inc. (the “Company”, “Dream”

BLUE OWL CAPITAL INC. reported financial results for the quarter ended March 31, 2024.

“On May 2, 2024, Blue Owl Capital Inc. (the “Company”) reported its financial results for the quarter ended March 31, 2024.”

Sotera Health Co reported three months ended March 31, 2024 results: revenue $248 million, net income $6 million, or $0.02 per diluted share, EPS $0.02 per diluted share. Guidance reaffirmed.

“incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sotera Health Reports First-Quarter 2024 Results • Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023 • Q1 2024 net income of $6 million or $0.02 per diluted share, comp ared to net income of $3 million or $0.01 per diluted share in Q1 2023 • Q1 2024 Adjusted”

Organon & Co. reported the first quarter ended March 31, 2024 results: revenue $1,622 million, net income $201 million, EPS $0.78. Guidance reaffirmed.

“First quarter 2024 revenue of $1,622 million, up 5% on an as-reported basis and 7% at constant currency • First quarter 2024 diluted earnings per share of $0.78 and non-GAAP Adjusted diluted earnings per share of $1.22; both reported and non-GAAP Adjusted diluted earnings per share include $15 million expense, or $(0.05) per share, for acquired in-process research and development (IPR&D) and milestones • First quarter 2024 net income of $201 million and Adjusted EBITDA (non-GAAP) of $538 million • Full year 2024 financial guidance ranges affirmed”

Sotera Health Co reported the three months ended March 31, 2024 results: revenue $248 million, net income $6 million, EPS $0.02 per diluted share. Guidance reaffirmed.

“First-quarter 2024 net revenues increased 12.5% to $248 million, compared to $221 million in the first-quarter 2023.”

SES AI Corp reported financial results for the fiscal quarter ended March 31, 2024.

“On May 2, 2024, SES AI Corporation (the “Company”) released a letter to its shareholders, which includes a business update and the Company’s financial results for the fiscal quarter ended March 31, 2024.”

Dyne Therapeutics, Inc. reported the quarter ended March 31, 2024 results: net income $65.6 million, or $0.81 per basic and diluted share, EPS $0.81 per basic and diluted share.

“Net loss for the quarter ended March 31, 2024 was $65.6 million, or $0.81 per basic and diluted share.”

Kymera Therapeutics, Inc. reported financial results for the quarter ended March 31, 2024.

“On May 2, 2024, Kymera Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2024.”

Relay Therapeutics, Inc. reported first quarter 2024 results: revenue $10.0 million, net income $81.4 million, EPS $0.62.

“The company expects its current cash, cash equivalents and investments will be sufficient to fund its current operating plan into the second half of 2026. Revenue: Revenue was $10.0 million for the first quarter of 2024, as compared to $0.2 million for the first quarter of 2023. The increase was primarily due to a payment of $10.0 million in connection with a”

Driven Brands Holdings Inc. reported the first quarter ending March 30, 2024 results: revenue $572 million, net income $4.3 million or $0.03 per diluted share, EPS $0.03 per diluted share. Guidance reaffirmed.

“DRVN) (“Driven Brands” or the “Company”) today reported financial results for the first quarter ending March 30, 2024. For the first quarter, Driven Brands delivered revenue of $572 million, up 2% versus the prior year. System-wide sales were $1.6 billion, up 7% versus the prior year primarily driven by 0.7% same store sales growth and 144 net new units. Net Income”

Rocket Companies, Inc. reported Q1'24 results: revenue $1.4 billion, net income $291 million, EPS $0.11 per GAAP diluted earnings per share.

“Generated Q1'24 total revenue, net of $1.4 billion and adjusted revenue of $1.2 billion. Adjusted revenue exceeded the high end of guidance range, and year-over-year growth accelerated for the third quarter in a row • Reported Q1'24 GAAP net income of $291 million, or $0.11 per GAAP diluted earnings per share and adjusted net income of $84 million, or $0.04 per adjusted diluted earnings per share • Delivered Q1'24 adjusted EBITDA of $174 million, the highest adjusted EBITDA in two years”

Rocket Companies, Inc. reported first quarter ended March 31, 2024 results: revenue $1,384, net income $291 million, EPS $0.11 per GAAP diluted earnings per share.

“our mission to help everyone home.” First Quarter 2024 Financial Summary 1 ROCKET COMPANIES ($ in millions, except per share amounts) Q1-24 Q1-23 (Unaudited) Total revenue, net $ 1,384 $ 666 Total expenses $ 1,085 $ 1,082 GAAP net income (loss) $ 291 $ (411) Adjusted revenue $ 1,163 $ 882 Adjusted net income (loss) $ 84 $ (111) Adjusted EBITDA $ 174 $ (79) GAAP”

MP Materials Corp. / DE reported three months ended March 31, 2024 results: revenue $48,684, net income $16,489, EPS $(0.08).

“Highlights For the three months ended March 31, 2024 vs. 2023 (unaudited) 2024 2023 Amount Change % Change Financial Measures: (in thousands, except per share data) Revenue (1) $ 48,684 $ 95,700 $ (47,016) (49) % Net income $ 16,489 $ 37,447 $ (20,958) (56) % Adjusted EBITDA (2) $ (1,233) $ 58,700 $ (59,933) N/M Adjusted Net Income (Loss) (2) $ (7,492) $ 51,327 $”

Xponential Fitness, Inc. reported first quarter ended March 31, 2024 results: revenue $79.5 million, net income net loss of $4.4 million, or a loss of $0.30 per basic share, EPS loss of $0.30 per basic share. Guidance reaffirmed.

“reconciliation to the corresponding GAAP measures are included in the tables that accompany this release. Financial Highlights: Q1 2024 Compared to Q1 2023 • Grew revenue 12% to $79.5 million. • Increased North America system-wide sales 1 by 25% to $401.1 million. • Reported North America same store sales 2 growth of 9%, compared to growth of 19%. • Reported North”

Opendoor Technologies Inc. reported the first quarter ended March 31, 2024 results: revenue $1.2 billion, net income $(109) million.

“the future of real estate, empowering consumers to sell and buy with ease through a simple, certain, and transparent offering.” First Quarter 2024 Key Highlights • Revenue of $1.2 billion, down (62)% versus 1Q23 and up 36% versus 4Q23; with 3,078 total homes sold, down (63)% versus 1Q23 and up 30% versus 4Q23 • Gross profit of $114 million, versus $170 million in”

Dun & Bradstreet Holdings, Inc. reported financial results for first quarter of 2024.

“On May 2, 2024, Dun & Bradstreet Holdings, Inc. (“Dun & Bradstreet” or the “Company”) issued a press release announcing its financial results for the first quarter of 2024.”

APi Group Corp reported the three months ended March 31, 2024 results: revenue $1,601, net income $45 million, EPS $(1.34).

“First Quarter 2024 Consolidated Results: Three Months Ended March 31, 2024 2023 Y/Y Y/Y (FFX) (a) Net revenues $ 1,601 $ 1,614 (0.8) % (1.2) % Organic net revenue growth (b) (1.4) % GAAP Gross profit $ 492 $ 425 15.8 % Gross margin 30.7 % 26.3 % + 440 bps Net income $ 45 $ 26 73.1 % Diluted EPS $ (1.34) $ 0.05 NM”

Vontier Corp reported the first quarter ended March 29, 2024 results: revenue $755.8 million, net income $136.8 million, EPS $0.88. Guidance reaffirmed.

“Mobility strategy, coupled with a comprehensive suite of industry-leading solutions and a commitment to innovation continue to drive growth and unlock value. • Sales of $756 million, down 3% vs. prior year; Core sales increased 4% • GAAP diluted net EPS of $0.88; Adjusted diluted net EPS of $0.74 above prior guide of $0.68 to $0.72 • Operating cash flow was”

BILL Holdings, Inc. reported third fiscal quarter ended March 31, 2024 results: revenue $323.0 million, net income $31.8 million, EPS $0.30 and $0.00 per share, basic and diluted. Guidance reaffirmed.

“increased 19% year-over-year while non-GAAP operating income increased 68% year-over-year.” Financial Highlights for the Third Quarter of Fiscal 2024: • Total revenue was $323.0 million, an increase of 19% year-over-year. • Core revenue, which consists of subscription and transaction fees, was $281.3 million, an increase of 17% year-over-year. Subscription fees”

Elevation Oncology, Inc. reported financial results for the first quarter ended March 31, 2024.

“On May 2, 2024, Elevation Oncology, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2024.”

OneWater Marine Inc. reported fiscal second quarter ended March 31, 2024 results: revenue $488 million, net income $(5) million, or $(0.27) per diluted share, EPS $(0.27) per diluted share. Guidance reaffirmed.

“Inc. Announces Fiscal Second Quarter 2024 Results Maintaining previously issued fiscal full year 2024 outlook Fiscal Second Quarter 2024 Highlights • Revenue decreased 7% to $488 million • Same-store sales decreased 5% for the quarter; average annual increase of 4% over last two years • Gross profit margin of 24.6% • GAAP net loss of $(5) million, or $(0.27) per”

SpringWorks Therapeutics, Inc. reported the quarter ended March 31, 2024 results: revenue $21.0 million, net income $87.4 million, EPS $1.18 per share.

“reference in such filing. --- EX-99.1 (EX-99.1) --- SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates – Achieved $21.0 million in OGSIVEO ® (nirogacestat) net product revenue in the first quarter – – Received validation from the EMA for MAA of nirogacestat for the treatment of adults with desmoid tumors”

STEM, INC. reported first quarter 2024 results: revenue $25.5 million, net income $72.3 million. Guidance reaffirmed.

“Stem Announces First Quarter 2024 Results Substantial increase of +42% CARR-to-ARR conversion since January 2024 Introducing Next Generation Asset Performance Management Software Suite Reaffirming Full Year 2024 Operating Cash Flow, Adjusted EBITDA, Gross Margin and Bookings Guidance First Quarter 2024 Financial and Operating Highlights Financial Highlights 1 • Revenue of $25.5 million, down from $67.4 million (-62%) in 1Q23.”

Palomar Holdings, Inc. reported the fiscal quarter ended March 31, 2024 results: revenue $368.1 million, net income $26.4 million, EPS $1.04 per diluted share. Guidance raised.

“of 2024 as compared to $20.4 million, or $0.80 per diluted share, for the first quarter of 2023 . First Quarter 2024 Highlights ● Gross written premiums increased by 47.2% to $368.1 million compared to $250.1 million in the first quarter of 2023 ● Net income of $26.4 million, compared to $17.3 million in the first quarter of 2023 ● Adjusted net income (1) of $27.8”

BICYCLE THERAPEUTICS PLC reported first quarter ended March 31, 2024 results: net income Net loss was $26.6 million, EPS $(0.62) basic and diluted net loss per share.

“Net loss was $26.6 million, or $(0.62) basic and diluted net loss per share, for the three months ended March 31, 2024”

Acadian Asset Management Inc. reported first quarter ended March 31, 2024 results: net income $14.6 million, EPS $0.37.

“BrightSphere Reports Financial and Operating Results for the First Quarter Ended March 31, 2024”

BridgeBio Pharma, Inc. reported financial results for first quarter ended March 31, 2024.

“BridgeBio Pharma, Inc. reported recent business updates and its financial results for the first quarter ended March 31, 2024.”

GRID DYNAMICS HOLDINGS, INC. reported First Quarter 2024 results: revenue $79.8 million, net income ($3.9 million), EPS ($0.05).

“Grid Dynamics Reports First Quarter 2024 Financial Results Revenue of $79.8 million and GAAP Net Loss of $3.9 million”

RESIDEO TECHNOLOGIES, INC. reported the first quarter ended March 30, 2024 results: revenue $1.49 billion, net income $43 million, EPS $0.29.

“and solutions for homes and businesses, today announced financial results for the first quarter ended March 30, 2024 . First Quarter 2024 Financial Highlights • Net revenue of $1.49 billion, down 4% compared to $1.55 billion in the first quarter 2023 • Net income of $43 million compared to $57 million in the first quarter 2023 • Fully diluted EPS of $0.29 and $0.38”

SolarWinds Corp reported first quarter ended March 31, 2024 results: revenue total revenue for the first quarter of $193.3 million, net income Net income for the first quarter of $15.6 million.

“and IT management software, today reported results for its first quarter ended March 31, 2024. First Quarter Financial Highlights • Total revenue for the first quarter of $193.3 million, representing 4% year-over-year growth, and total recurring revenue representing 93% of total revenue. • Net income for the first quarter of $15.6 million. • Adjusted EBITDA for”

Cigna Group reported first quarter 2024 results: revenue $57.3 billion, net income $0.3 billion, EPS $0.97 per share. Guidance raised.

“The Cigna Group Reports Strong First Quarter 2024 Results, Raises 2024 Outlook • Total revenues for the first quarter 2024 were $57.3 billion • Shareholders’ net loss for the first quarter 2024 was $0.3 billion, or $0.97 per share”

Utz Brands, Inc. reported the first quarter ended March 31, 2024 results: revenue $346.5 million, net income $2.4 million, EPS Basic loss per share of $(0.05). Guidance reaffirmed.

“and a small-cap growth and value Staples equity, today reported financial results for the Company’s fiscal first quarter ended March 31, 2024. 1Q’24 Summary (1) • Net sales of $346.5 million • Organic Net Sales increased 1.5% • Gross Profit Margin expansion of 480 bps • Adjusted Gross Margin expansion of 280 bps • Net income of $2.4 million vs. net loss of $(14.5)”

Arcosa, Inc. reported first quarter ended March 31, 2024 results: revenue $598.6, net income $39.2, EPS $0.80. Guidance raised.

“for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Three Months Ended March 31, 2024 2023 % Change ($ in millions, except per share amounts) Revenues $ 598.6 $ 549.2 9 % Net income $ 39.2 $ 55.7 (30) % Adjusted Net Income (1)(2) $ 36.0 $ 51.7 (30) % Diluted EPS (2) $ 0.80 $ 1.14 (30) % Adjusted Diluted EPS (1)(2) $ 0.73 $ 1.06 (31) %”

WestRock Co reported second quarter of fiscal 2024 results: revenue Net sales of $4.73 billion, net income Net income of $16 million, EPS Earnings of $0.06 per diluted share.

“paper and packaging solutions, today announced results for its fiscal second quarter ended March 31, 2024. Second Quarter Highlights and other notable items: • Net sales of $4.73 billion • Net income of $16 million, Adjusted Net Income of $101 million; net income included $81 million of restructuring and other costs, net • Earnings of $0.06 per diluted share”

Frontdoor, Inc. reported fiscal quarter ended March 31, 2024 results: revenue $378 million, net income $34 million, EPS $0.43 per diluted share. Guidance raised.

“be expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Frontdoor Announces First-Quarter 2024 Revenue Increased 3% to $378 Million; Gross Profit Margin Expanded 510 bps to 51%; Net Income of $34 Million and Adjusted EBITDA (1) of $71 Million; Raising Full-Year 2024 Gross Profit Margin and Adjusted EBITDA (2)”

Ranpak Holdings Corp. reported first quarter ended March 31, 2024 results: revenue $85.3 million, net income $8.1 million net loss.

“• Packaging System placement up 0.9% year over year to approximately 140,800 machines at March 31, 2024 • Net revenue for the first quarter increased 5.0% year over year to $85.3 million and increased 4.4% year over year on a constant currency basis to $88.5 million • Net loss for the first quarter of $8.1 million compared to net loss of $12.4 million for the”

Custom Truck One Source, Inc. reported three months ended March 31, 2024 results: revenue $411.3 million, net income Net loss of $14.3 million.

“and other infrastructure-related end markets, today reported financial results for its three months ended March 31, 2024. CTOS First-Quarter Highlights • Total revenue of $411.3 million, a decrease of $40.9 million, or 9.0%, compared to $452.2 million for the first quarter of 2023 primarily due to fewer rental asset sales and lower rental demand from the utility”

Ecovyst Inc. reported the quarter ended March 31, 2024 results: revenue $160.5 million, net income $1.2 million, EPS $0.01.

“of advanced materials, specialty catalysts and services, today reported results for the first quarter ended March 31, 2024. First Quarter 2024 Results & Highlights ▪ Sales of $160.5 million, compared to $160.9 million in the first quarter of 2023, reflecting higher sales volume in virgin sulfuric acid and regeneration services, offset by lower sales of advanced”

LINDE PLC reported the quarter ended March 31, 2024 results: revenue $8,100 million, net income $1,627 million, EPS $3.35. Guidance initiated.

“--- EX-99.1 (PRESS RELEASE) --- EX-99.1 2 linde_ex991.htm PRESS RELEASE linde_ex991.htm EXHIBIT 99.1 Linde Reports First-Quarter 2024 Results First-Quarter Highlights ➢ Sales $8.1 billion, down 1%, underlying sales up 1% ➢ Operating profit $2.1 billion, adjusted operating profit $2.3 billion, up 6% ➢ Operating profit margin 25.9%; adjusted operating profit margin”

Vir Biotechnology, Inc. reported first quarter ended March 31, 2024 results: revenue $56.4 million.

“cash equivalents and investments declined by approximately $118 million during the first quarter of 2024. Revenues: Total revenues for the quarter ended March 31, 2024, were $56.4 million compared to $63.0 million for the same period in 2023. Revenues were comprised of the following components: Three Months Ended March 31, 2024 2023 % Change (in millions)”

Optimum Communications, Inc. reported the quarter ended March 31, 2024 results: revenue $2.3 billion, net income ($21.2) million, EPS ($0.05) per diluted share.

“customer relationships and elevating network and service quality, all while maintaining financial discipline." First Quarter 2024 Financial Overview • Total Revenue of $2.3 billion (-1.9% year over year). • Residential Revenue (1) of $1.8 billion (-2.9% year over year). • Residential Revenue per user (ARPU) (2) of $135.67 (+0.3% or +$0.35 year over year). •”

Altair Engineering Inc. reported first quarter ended March 31, 2024 results: revenue $172.9 million, net income $16.5 million, EPS $0.20 per diluted share. Guidance reaffirmed.

“Total revenue was $172.9 million compared to $166.0 million for the first quarter of 2023, an increase of 4.1% in reported currency and 5.1% in constant currency • Net income was $16.5 million compared to a net loss of $(2.0) million for the first quarter of 2023. Net income per share, diluted was $0.20 based on 89.8 million diluted weighted average common shares outstanding”

Cactus, Inc. reported first quarter ended March 31, 2024 results: revenue Revenue of $274.1 million, net income Net income of $49.8 million, EPS diluted earnings per Class A share of $0.59.

“2024 – Cactus, Inc. (NYSE: WHD) (“Cactus” or the “Company”) today announced financial and operating results for the first quarter of 2024. First Quarter Highlights • Revenue of $274.1 million and operating income of $62.6 million; • Net income of $49.8 million and diluted earnings per Class A share of $0.59; • Adjusted net income (1) of $59.6 million and diluted”

Ingersoll Rand Inc. reported the quarter ended March 31, 2024 results: revenue $1,670 million, net income $202 million, EPS $0.50 per share. Guidance raised.

“Excellence (IRX): • First quarter orders of $1,707 million, down 4%, or down 7% organic ◦ On a two-year stack, up 5%, or up 1% organic • Reported first quarter revenues of $1,670 million, up 3%, or down 1% organic 1 ◦ On a two-year stack, up 24%, or up 20% organic 1 • Reported net income attributable to Ingersoll Rand Inc. of $202 million, or earnings of $0.50”

Schneider National, Inc. reported the three months ended March 31, 2024 results: revenue $ 1,319.0, net income $ 18.5, EPS $0.10. Guidance reaffirmed.

“the Company’s results of operations for the periods indicated. Three Months Ended March 31, (in millions, except ratios & per share amounts) 2024 2023 Change Operating revenues $ 1,319.0 $ 1,428.7 (8)% Revenues (excluding fuel surcharge) 1,163.1 1,249.5 (7)% Income from operations 28.7 114.6 (75)% Adjusted income from operations 30.0 114.6 (74)% Operating ratio”

Moderna, Inc. reported the first quarter ended March 31, 2024 results: revenue $167 million, net income GAAP net loss of $1.2 billion, EPS GAAP diluted EPS of $(3.07). Guidance reaffirmed.

“Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates Reports first quarter revenues of $167 million , GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07) Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 expected product sales of approximately $4 billion”